NCT05591989 - Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Chronic Rhinitis

Interventions

DEVICE

NEUROMARK System

The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

Trial Locations (10)

18017

Specialty Physician Associates, Bethlehem

21204

Centers for Advanced ENT Care (CAdENT), Baltimore

23235

Richmond ENT, Richmond

35242

Alabama Nasal and Sinus Center (Alabama Allergy), Birmingham

48073

Rontal Clinics, Royal Oak

70072

New Orleans Sinus Center, Marrero

80923

Colorado ENT, Colorado Springs

92592

United Medical Doctors, Temecula

95661

Sacramento ENT, California City

98374-1145

Ear Nose Throat & Allergy Associates, Seattle